Now showing items 1-4 of 4
Comparative Legal Review: Reassessing the Social Contract in Europe and the United States for Patenting Human Genetic Materials
(Queen Mary University of London, 2015-01-26)
In 2013, the US Supreme Court declared isolated gene sequences as ‘products of nature’ and hence, unpatentable subject matter. Paradoxically, the European Patent Office (EPO), relying on the EU Biotech Directive 98/44/EC, ...
The International Trade: Dispute over GMO's before the WTO: Causes and Consequences
(Queen Mary University of London, 2014-07-08)
The Biotech dispute at WTO received a great deal of attention, and reopened a wide-ranging debate over the benefits of genetically modified organisms (GMOs) and their effects on human health and the environment. The dispute ...
An empirical study on biotechnology and intellectual property rights: the case for open scientific innovation in Brazil
(Queen Mary University of London, 2013-09)
This thesis investigates the interaction between biotechnology, intellectual property rights and Open Scientific Innovation (OSI). The current intellectual property rights - dependent business models prevailing within the ...
STIMULATING INNOVATION IN BRAZIL: A STUDY OF INTELLECTUAL PROPERTY LAW, BIOTECHNOLOGY AND OPEN SCIENTIFIC INNOVATION
(Queen Mary University of London, 2017-01-31)
The Agreement on Trade-Related Aspects of Intellectual Property (TRIPS) administered by the World Trade Organization affects a wide range of domestic public policies and industry practices in biotechnology. With the advent ...